2026 Journal Metrics Score
0.0
Updated August 2026 · 2-year citation average from OpenAlex data
The Journal Metrics Score is the two-year mean citedness of a journal, computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works. Quartiles rank journals within each OpenAlex subfield by score. Data source: OpenAlex (CC0).
Bookmark this page — track this journal's Journal Metrics Score, quartile and field rankings with every OpenAlex data release.
| Category | Quartile |
|---|---|
| Epidemiology | Q4 |
| Infectious Diseases | Q4 |
| Geriatrics and Gerontology | Q4 |
| Endocrinology, Diabetes and Metabolism | Q4 |
A lower-cited Q4 journal by citation data
By citation data, Us Pharmacist is in the lowest quartile in Epidemiology and 3 other subfields and ranks #6,262 of 6,272 Medicine journals by Journal Metrics Score (top 100%). A Q4 placement means its papers are cited less than most in the subfield; on its own it does not mean the journal is predatory or that its peer review is weak. Us Pharmacist's 2026 Journal Metrics Score is 0.0. OpenAlex classifies its papers in subfields including Epidemiology, Infectious Diseases, and Geriatrics and Gerontology, so check that your topic fits its scope.
Verdict from citation data only: quartile and field rank by Journal Metrics Score (OpenAlex), publisher-reported acceptance rates, and PubMed submission and acceptance dates. See how we rank journals and how to verify indexing.
Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.
Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.
Us Pharmacist's 2026 Journal Metrics Score is 0.0, updated August 2026 from OpenAlex citation data. The journal is ranked Q4 in this Journal Metrics record.
OpenAlex lists these research topics for Us Pharmacist's papers: Nail Diseases and Treatments, COVID-19 Clinical Research Studies, Pharmaceutical Practices and Patient Outcomes, and Diabetes Management and Research.
OpenAlex records 33 citations to papers published in Us Pharmacist, and 1 of its papers has been cited at least 10 times (i10-index).
Before using this record in a shortlist or submission decision, confirm the title and ISSN against the journal homepage and its OpenAlex record. Our methodology explains how the score and quartiles are computed.
Ranked #6,262 in Medicine by Journal Metrics Score and #1,095 among Q4 Medicine journals. This context helps compare Us Pharmacist against journals publishing in the same field.
Published 15 papers across the last 5 recorded years with a current Journal Metrics Score of 0.0.
Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.
OpenAlex classifies Us Pharmacist's papers in subfields including Epidemiology, Infectious Diseases, and Geriatrics and Gerontology. Read the aims and scope page and a few recent papers close to your topic before you prepare the manuscript.
Article types, word and figure limits, reference style, and the required statements (data availability, ethics, conflicts of interest, author contributions) are set by the journal. Prepare the cover letter and files to match them.
Us Pharmacist homepage ↗Use the submit link in Us Pharmacist's author guidelines. Every author usually needs an ORCID iD, and the corresponding author needs an account on the submission site.
OpenAlex has no article processing charge on record. Check the journal website for page charges or an optional open-access fee.
Us Pharmacist does not publish an acceptance rate.
Reviewer Two · coming soon
An AI pre-submission report on your manuscript: the objections a tough reviewer is likely to raise, desk-rejection risks, and better-fit journals from our data. $29 per report.
See what the report coversBy citation data, Us Pharmacist is in the lowest quartile in Epidemiology and 3 other subfields and ranks #6,262 of 6,272 Medicine journals by Journal Metrics Score (top 100%). A Q4 placement means its papers are cited less than most in the subfield; on its own it does not mean the journal is predatory or that its peer review is weak. Us Pharmacist's 2026 Journal Metrics Score is 0.0. OpenAlex classifies its papers in subfields including Epidemiology, Infectious Diseases, and Geriatrics and Gerontology, so check that your topic fits its scope.
We have not found an official acceptance rate published by Us Pharmacist or its publisher, and Journal Metrics does not estimate one because submission counts are not public. To judge selectivity, compare Us Pharmacist's quartile and score with similar journals, or ask the editorial office.
Submit online through the link in Us Pharmacist's author guidelines on the journal homepage. Before submitting, check the scope, follow the author guidelines for article type, length, and required statements, and prepare a cover letter.
Papers Us Pharmacist published each year, and citations its papers received in that year, from OpenAlex.